Abstract
Obstructive sleep apnea (OSA) is a highly prevalent sleep disorder leading to cardiovascular and metabolic complications. OSA is also a multicomponent disorder, with intermittent hypoxia (IH) as the main trigger for the associated cardiovascular and metabolic alterations. Indeed, recurrent pharyngeal collapses during sleep lead to repetitive sequences of hypoxia–reoxygenation. This IH induces several consequences such as hemodynamic, hormonometabolic, oxidative, and immuno-inflammatory alterations that may interact and aggravate each other, resulting in artery changes, from adaptive to degenerative atherosclerotic remodeling. Atherosclerosis has been found in OSA patients free of other cardiovascular risk factors and is related to the severity of nocturnal hypoxia. Early stages of artery alteration, including functional and structural changes, have been evidenced in both OSA patients and rodents experimentally exposed to IH. Impaired vasoreactivity with endothelial dysfunction and/or increased vasoconstrictive responses due to sympathetic, endothelin, and renin–angiotensin systems have been reported and also contribute to vascular remodeling and inflammation. Oxidative stress, inflammation, and vascular remodeling can be directly triggered by IH, further aggravated by the OSA-associated hormonometabolic alterations, such as insulin resistance, dyslipidemia, and adipokine imbalance. As shown in OSA patients and in the animal model, genetic susceptibility, comorbidities (obesity), and life habits (high fat diet) may aggravate atherosclerosis development or progression. The intimate molecular mechanisms are still largely unknown, and their understanding may contribute to delineate new targets for prevention strategies and/or development of new treatment of OSA-related atherosclerosis, especially in patients at risk for cardiovascular disease.
Similar content being viewed by others
Abbreviations
- AHI:
-
Apnea–hypopnea index
- BP:
-
Blood pressure
- CPAP:
-
Continuous positive airway pressure
- CRP:
-
C-reactive protein
- EDS:
-
Excessive daytime sleepiness
- ET-1:
-
Endothelin-1
- HIF-1:
-
Hypoxia inducible factor-1
- ICAM-1:
-
Intercellular adhesion molecule-1
- IH:
-
Intermittent hypoxia
- IL:
-
Interleukin
- IMT:
-
Intima–media thickness
- LTB4:
-
Leukotriene B4
- MCP-1/CCL2:
-
Monocyte chemoattractant protein-1/C–C chemokine ligand 2
- OSA:
-
Obstructive sleep apnea
- NFkB:
-
Nuclear factor kappa B
- PECAM-1:
-
Platelet endothelial cell adhesion molecule-1
- RANTES/CCL5:
-
Regulated upon activation, normal T cell expressed and secreted/C–C chemokine ligand 5
- TNF-α:
-
Tumor necrosis factor-alpha
- VCAM-1:
-
Vascular cell adhesion molecule-1
References
Malhotra A, White DP (2002) Obstructive sleep apnoea. Lancet 360(9328):237–245. doi:10.1016/S0140-6736(02) 09464-3
Somers VK et al (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 118(10):1080–1111. doi:10.1161/CIRCULATIONAHA.107.189420
Mayer P et al (1996) Relationship between body mass index, age and upper airway measurements in snorers and sleep apnoea patients. Eur Respir J 9(9):1801–1809. doi:10.1183/09031936.96.09091801
White DP (2005) Pathogenesis of obstructive and central sleep apnea. Am J Respir Crit Care Med 172(11):1363–1370. doi:10.1164/rccm.200412-1631SO
Horner RL (2007) Contributions of passive mechanical loads and active neuromuscular compensation to upper airway collapsibility during sleep. J Appl Physiol 102(2):510–512. doi:10.1152/japplphysiol.01213.2006
Levy P et al (2008) Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives. Eur Respir J 32(4):1082–1095. doi:10.1183/09031936.00013308
Young T et al (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328(17):1230–1235. doi:10.1056/NEJM199304293281704
Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165(9):1217–1239. doi:10.1164/rccm.2109080
Teran-Santos J, Jimenez-Gomez A, Cordero-Guevara J (1999) The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander. N Engl J Med 340(11):847–851. doi:10.1056/NEJM199903183401104
Mazza S et al (2002) Analysis of error profiles occurring during the OSLER test: a sensitive mean of detecting fluctuations in vigilance in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 166(4):474–478. doi:10.1164/rccm.2107065
Marin JM et al (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea–hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365(9464):1046–1053
Pepperell JC et al (2002) Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359(9302):204–210. doi:10.1016/S0140-6736(02)07445-7
Yaggi HK et al (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353(19):2034–2041. doi:10.1056/NEJMoa043104
Somers VK et al (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 52(8):686–717. doi:10.1016/j.jacc.2008.05.002
Young T et al (2008) Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 31(8):1071–1078
Baguet JP et al (2005) The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest 128(5):3407–3412. doi:10.1378/chest.128.5.3407
Minoguchi K et al (2005) Increased carotid intima–media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172(5):625–630. doi:10.1164/rccm.200412-1652OC
Drager LF et al (2005) Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172(5):613–618. doi:10.1164/rccm.200503-340OC
Turmel J et al (2009) Relationship between atherosclerosis and the sleep apnea syndrome: an intravascular ultrasound study. Int J Cardiol 132(2):203–209. doi:10.1016/j.ijcard.2007.11.063
Basner RC (2007) Continuous positive airway pressure for obstructive sleep apnea. N Engl J Med 356(17):1751–1758. doi:10.1056/NEJMct066953
Jenkinson C et al (1999) Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 353(9170):2100–2105. doi:10.1016/S0140-6736(98)10532-9
Montserrat JM et al (2001) Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome. A randomized controlled study with an optimized placebo. Am J Respir Crit Care Med 164(4):608–613
Haentjens P et al (2007) The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 167(8):757–764. doi:10.1001/archinte.167.8.757
Lévy P et al (2009) Obstructive sleep apnea and atherosclerosis. Prog Cardiovasc Dis 51(5):400–410. doi:10.1016/j.pcad.2008.03.001
Gay P et al (2006) Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep 29(3):381–401
Pepin JL et al (1999) Effective compliance during the first 3 months of continuous positive airway pressure. A European prospective study of 121 patients. Am J Respir Crit Care Med 160(4):1124–1129
Weaver TE et al (2007) Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 30(6):711–719
Harsch IA et al (2004) Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169(2):156–162. doi:10.1164/rccm.200302-206OC
Coughlin SR et al (2007) Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 29(4):720–727. doi:10.1183/09031936.00043306
West SD et al (2007) Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 62(11):969–974. doi:10.1136/thx.2006.074351
Dematteis M et al. (2009) Cardiovascular consequences of sleep disordered breathing: contribution of animal models to understanding the human disease. ILAR J 50(3)
Kimoff RJ et al (1994) Canine model of obstructive sleep apnea: model description and preliminary application. J Appl Physiol 76(4):1810–1817
Brooks D et al (1997) Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 99(1):106–109. doi:10.1172/JCI119120
Nacher M et al (2007) Recurrent obstructive apneas trigger early systemic inflammation in a rat model of sleep apnea. Respir Physiol Neurobiol 155(1):93–96. doi:10.1016/j.resp. 2006.06.004
Neubauer JA (2001) Invited review: physiological and pathophysiological responses to intermittent hypoxia. J Appl Physiol 90(4):1593–1599
Fletcher EC (2001) Invited review: physiological consequences of intermittent hypoxia: systemic blood pressure. J Appl Physiol 90(4):1600–1605
Morgan BJ (2007) Vascular consequences of intermittent hypoxia. Adv Exp Med Biol 618:69–84. doi:10.1007/978-0-387-75434-5_6
Prabhakar NR (2001) Oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms. J Appl Physiol 90(5):1986–1994
Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165(7):934–939
Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112(17):2660–2667. doi:10.1161/CIRCULATIONAHA.105.556746
Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352(16):1685–1695. doi:10.1056/NEJMra043430
Libby P (2002) Inflammation in atherosclerosis. Nature 420(6917):868–874. doi:10.1038/nature01323
Lusis AJ (2000) Atherosclerosis. Nature 407(6801):233–241. doi:10.1038/35025203
Peppard PE et al (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342(19):1378–1384. doi:10.1056/NEJM200005113421901
Brooks D et al (1997) Effect of obstructive sleep apnea versus sleep fragmentation on responses to airway occlusion. Am J Respir Crit Care Med 155(5):1609–1617
Smith ML, Pacchia CF (2007) Sleep apnoea and hypertension: role of chemoreflexes in humans. Exp Physiol 92(1):45–50. doi:10.1113/expphysiol.2006.033753
Somers VK et al (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96(4):1897–1904. doi:10.1172/JCI118235
Dematteis M et al (2008) Intermittent hypoxia induces early functional cardiovascular remodeling in mice. Am J Respir Crit Care Med 177(2):227–235. doi:10.1164/rccm.200702-238OC
Chatzizisis YS et al (2007) Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol 49(25):2379–2393. doi:10.1016/j.jacc.2007.02.059
Kato M et al (2000) Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102(21):2607–2610
Kraiczi H et al (2001) Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest 119(4):1085–1091. doi:10.1378/chest.119.4.1085
Imadojemu VA et al (2002) Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy. Am J Respir Crit Care Med 165(7):950–953
Imadojemu VA et al (2002) Obstructive apnea during sleep is associated with peripheral vasoconstriction. Am J Respir Crit Care Med 165(1):61–66
Tahawi Z et al (2001) Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats. J Appl Physiol 90(5):2007–2013 discussion 2000
Phillips SA et al (2004) Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 286(1):H388–H393. doi:10.1152/ajpheart.00683.2003
Lefebvre B et al (2006) Functional assessment of vascular reactivity after chronic intermittent hypoxia in the rat. Respir Physiol Neurobiol 150(2–3):278–286. doi:10.1016/j.resp. 2005.05.020
Ip MS et al (2000) Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 162(6):2166–2171
Lavie L et al (2003) Plasma levels of nitric oxide and L-arginine in sleep apnea patients: effects of nCPAP treatment. J Mol Neurosci 21(1):57–63. doi:10.1385/JMN:21:1:57
Teramoto S et al (2003) Oxygen administration improves the serum level of nitric oxide metabolites in patients with obstructive sleep apnea syndrome. Sleep Med 4(5):403–407. doi:10.1016/S1389-9457(03)00102-3
Ohike Y et al (2005) Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure—possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J 69(2):221–226. doi:10.1253/circj.69.221
Duchna HW et al (2005) Long-term effects of nasal continuous positive airway pressure on vasodilatory endothelial function in obstructive sleep apnea syndrome. Sleep Breath 9(3):97–103. doi:10.1007/s11325-005-0024-z
Lattimore JL et al (2006) Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax 61(6):491–495. doi:10.1136/thx.2004.039164
Noda A et al (2007) Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome. Hypertens Res 30(8):669–676. doi:10.1291/hypres.30.669
Ozkan Y et al (2008) Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea–hypopnea syndrome (OSAHS). Sleep Breath 12(2):149–154. doi:10.1007/s11325-007-0148-4
Mason RP (2006) Nitric oxide mechanisms in the pathogenesis of global risk. J Clin Hypertens (Greenwich) 8(8 Suppl 2):31–38. doi:10.1111/j.1524-6175.2006.05838.x quiz 40
Belaidi E et al (2009) Major role for HIF-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. J Am Coll Cardiol 53(15):1309–1317
Mulvany MJ et al (1996) Vascular remodeling. Hypertension 28(3):505–506
Drager LF et al (2007) Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176(7):706–712. doi:10.1164/rccm.200703-500OC
Arnaud C et al. (2008) Intermittent hypoxia induces inflammatory vascular remodeling in C57bl6 mice. In: American Thoracic Society 2008 International Conference. Am J Resp Crit Care Med 177, Meeting abstracts, 2008, Toronto, Canada
Belaidi E et al. (2008) Dual endothelin-1 receptor antagonism prevents chronic intermittent hypoxia-induced cardiovascular alterations in rat. In: European Respiratory Society 2008 International Conference. Eur Resp J 32(suppl 52), Meeting abstract, 2008, Berlin, Germany
Arnaud C et al. (2009) Intermittent hypoxia induces inflammatory vascular and myocardial remodeling: role of the endothelin system. In: American Thoracic Society 2009 International Conference. Am J Respir Crit Care Med 179, Meeting Abstracts, 2009, San Diego, USA
Allahdadi KJ, Walker BR, Kanagy NL (2005) Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 45(4):705–709. doi:10.1161/01.HYP.0000153794.52852.04
Lefebvre B et al (2008) Leukotriene B4: early mediator of atherosclerosis in obstructive sleep apnoea? Eur Respir J 32(1):113–120. doi:10.1183/09031936.00137107
Chapman MJ, Sposito AC (2008) Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy. Pharmacol Ther 117(3):354–373. doi:10.1016/j.pharmthera.2007.10.004
Newman AB et al (2005) Progression and regression of sleep-disordered breathing with changes in weight: the sleep heart health study. Arch Intern Med 165(20):2408–2413. doi:10.1001/archinte.165.20.2408
Peled N et al (2007) The association of OSA with insulin resistance, inflammation and metabolic syndrome. Respir Med 101(8):1696–1701. doi:10.1016/j.rmed.2007.02.025
Kono M et al (2007) Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 131(5):1387–1392. doi:10.1378/chest.06-1807
Meslier N et al (2003) Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J 22(1):156–160. doi:10.1183/09031936.03.00089902
Strohl KP et al (1994) Insulin levels, blood pressure and sleep apnea. Sleep 17(7):614–618
Vgontzas AN et al (2000) Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85(3):1151–1158. doi:10.1210/jc.85.3.1151
Ip MS et al (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165(5):670–676
McArdle N et al (2007) Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 175(2):190–195. doi:10.1164/rccm.200602-270OC
Punjabi NM et al (2002) Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165(5):677–682
Stoohs RA, Facchini F, Guilleminault C (1996) Insulin resistance and sleep-disordered breathing in healthy humans. Am J Respir Crit Care Med 154(1):170–174
Sharma SK et al (2007) Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 8(1):12–17. doi:10.1016/j.sleep. 2006.06.014
Barcelo A et al (2008) Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax 63(11):946–950. doi:10.1136/thx.2007.093740
Polotsky VY et al (2009) Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity. Am J Respir Crit Care Med 179(3):228–234. doi:10.1164/rccm.200804-608OC
Muniyappa R et al (2007) Cardiovascular actions of insulin. Endocr Rev 28(5):463–491. doi:10.1210/er.2007-0006
Nigro J et al (2006) Insulin resistance and atherosclerosis. Endocr Rev 27(3):242–259. doi:10.1210/er.2005-0007
Polotsky VY et al (2003) Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 552(Pt 1):253–264. doi:10.1113/jphysiol.2003.048173
Martin SS, Qasim A, Reilly MP (2008) Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol 52(15):1201–1210. doi:10.1016/j.jacc.2008.05.060
Dubey L, Hesong Z (2006) Role of leptin in atherogenesis. Exp Clin Cardiol 11(4):269–275
Beltowski J (2006) Leptin and atherosclerosis. Atherosclerosis 189(1):47–60. doi:10.1016/j.atherosclerosis.2006.03.003
Sierra-Johnson J et al (2008) Effect of altitude on leptin levels, does it go up or down? J Appl Physiol 105(5):1684–1685. doi:10.1152/japplphysiol.01284.2007
Grosfeld A et al (2002) Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem 277(45):42953–42957. doi:10.1074/jbc.M206775200
Barcelo A et al (2005) Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity. Am J Respir Crit Care Med 171(2):183–187. doi:10.1164/rccm.200405-579OC
Borgel J et al (2006) Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels. Eur Respir J 27(1):121–127. doi:10.1183/09031936.06.00131304
Saarelainen S, Lahtela J, Kallonen E (1997) Effect of nasal CPAP treatment on insulin sensitivity and plasma leptin. J Sleep Res 6(2):146–147
Chin K et al (1999) Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100(7):706–712
Ip MS et al (2000) Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 118(3):580–586. doi:10.1378/chest.118.3.580
Shimizu K et al (2002) Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea–hypopnoea syndrome. Thorax 57(5):429–434. doi:10.1136/thorax.57.5.429
Okamoto Y et al (2006) Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (Lond) 110(3):267–278. doi:10.1042/CS20050182
Gualillo O, Gonzalez-Juanatey JR, Lago F (2007) The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives. Trends Cardiovasc Med 17(8):275–283. doi:10.1016/j.tcm.2007.09.005
Lago F et al (2007) Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol 3(12):716–724. doi:10.1038/ncprheum0674
Makino S et al (2006) Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol (Oxf) 64(1):12–19. doi:10.1111/j.1365-2265.2005.02407.x
Tokuda F et al (2008) Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome. Intern Med 47(21):1843–1849. doi:10.2169/internalmedicine.47.1035
Wolk R et al (2005) Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea. Obes Res 13(1):186–190. doi:10.1038/oby.2005.24
Zhang XL et al (2004) Serum adiponectin level in patients with obstructive sleep apnea hypopnea syndrome. Chin Med J (Engl) 117(11):1603–1606
Zhang XL et al (2006) Serum adiponectin levels in adult male patients with obstructive sleep apnea hypopnea syndrome. Respiration 73(1):73–77. doi:10.1159/000088690
Masserini B et al (2006) Reduced levels of adiponectin in sleep apnea syndrome. J Endocrinol Invest 29(8):700–705
Zhang XL et al (2007) Effect of continuous positive airway pressure treatment on serum adiponectin level and mean arterial pressure in male patients with obstructive sleep apnea syndrome. Chin Med J (Engl) 120(17):1477–1481
Nakagawa Y et al (2008) Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea–hypopnea syndrome. Am J Physiol Endocrinol Metab 294(4):E778–E784. doi:10.1152/ajpendo.00709.2007
Kanbay A et al (2008) Comparison of serum adiponectin and tumor necrosis factor-alpha levels between patients with and without obstructive sleep apnea syndrome. Respiration 76(3):324–330. doi:10.1159/000134010
Lam JC et al (2008) Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea. Sleep 31(12):1721–1727
Chen B et al (2006) Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. Biochem Biophys Res Commun 341(2):549–556. doi:10.1016/j.bbrc.2006.01.004
Hosogai N et al (2007) Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56(4):901–911. doi:10.2337/db06-0911
Wang B, Wood IS, Trayhurn P (2007) Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch 455(3):479–492. doi:10.1007/s00424-007-0301-8
Ye J et al (2007) Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293(4):E1118–E1128. doi:10.1152/ajpendo.00435.2007
Magalang UJ et al (2008) Intermittent hypoxia suppresses adiponectin secretion by adipocytes. Exp Clin Endocrinol Diabetes 117:129–134
Yamamoto Y et al (2008) Resistin is closely related to systemic inflammation in obstructive sleep apnea. Respiration 76(4):377–385. doi:10.1159/000141866
Wu H et al (2007) T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 115(8):1029–1038. doi:10.1161/CIRCULATIONAHA.106.638379
Thalmann S, Meier CA (2007) Local adipose tissue depots as cardiovascular risk factors. Cardiovasc Res 75(4):690–701. doi:10.1016/j.cardiores.2007.03.008
Henrichot E et al (2005) Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis? Arterioscler Thromb Vasc Biol 25(12):2594–2599. doi:10.1161/01.ATV.0000188508.40052.35
McGill HC Jr et al (2002) Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 105(23):2712–2718. doi:10.1161/01.CIR.0000018121.67607.CE
Fantuzzi G, Mazzone T (2007) Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol 27(5):996–1003. doi:10.1161/ATVBAHA.106.131755
Ohman MK et al (2008) Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 117(6):798–805. doi:10.1161/CIRCULATIONAHA.107.717595
Vela D et al (2007) The role of periadventitial fat in atherosclerosis. Arch Pathol Lab Med 131(3):481–487
Newman AB et al (2001) Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 154(1):50–59. doi:10.1093/aje/154.1.50
Robinson GV et al (2004) Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 59(9):777–782. doi:10.1136/thx.2003.018739
Lavie L (2003) Obstructive sleep apnoea syndrome—an oxidative stress disorder. Sleep Med Rev 7(1):35–51. doi:10.1053/smrv.2002.0261
Tan KC et al (2005) HDL dysfunction in obstructive sleep apnea. Atherosclerosis 184:377–382
Lavie L, Vishnevsky A, Lavie P (2004) Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27(1):123–128
Li J et al (2005) Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res 97(7):698–706. doi:10.1161/01.RES.0000183879.60089.a9
Li J et al (2007) Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol 102(2):557–563. doi:10.1152/japplphysiol.01081.2006
Lattimore JD et al (2005) Repetitive hypoxia increases lipid loading in human macrophages—a potentially atherogenic effect. Atherosclerosis 179(2):255–259. doi:10.1016/j.atherosclerosis.2004.11.010
Savransky V et al (2007) Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 175(12):1290–1297. doi:10.1164/rccm.200612-1771OC
Savransky V et al (2008) Dyslipidemia and atherosclerosis induced by chronic intermittent hypoxia are attenuated by deficiency of stearoyl coenzyme A desaturase. Circ Res 103(10):1173–1180. doi:10.1161/CIRCRESAHA.108.178533
McNicholas WT, Bonsignore MR (2007) Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29(1):156–178. doi:10.1183/09031936.00027406
Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444(7121):860–867. doi:10.1038/nature05485
Shamsuzzaman AS et al (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105(21):2462–2464. doi:10.1161/01.CIR.0000018948.95175.03
Yokoe T et al (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107(8):1129–1134. doi:10.1161/01.CIR.0000052627.99976.18
Yao M et al (2006) The relationship between sleep-disordered breathing and high-sensitivity C-reactive protein in Japanese men. Sleep 29(5):661–665
Taheri S et al (2007) Correlates of serum C-reactive protein (CRP)—no association with sleep duration or sleep disordered breathing. Sleep 30(8):991–996
Guilleminault C, Kirisoglu C, Ohayon MM (2004) C-reactive protein and sleep-disordered breathing. Sleep 27(8):1507–1511
Kohler M et al (2009) Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial. Thorax 64(1):67–73. doi:10.1136/thx.2008.097931
Carpagnano GE et al (2002) Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest 122(4):1162–1167. doi:10.1378/chest.122.4.1162
Ohga E et al (1999) Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 87(1):10–14
Ohga E et al (2003) Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94(1):179–184
Schulz R et al (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162(2 Pt 1):566–570
Dyugovskaya L et al (2008) Delayed neutrophil apoptosis in patients with sleep apnea. Am J Respir Crit Care Med 177(5):544–554. doi:10.1164/rccm.200705-675OC
Dyugovskaya L et al (2005) Activated CD8+ T-lymphocytes in obstructive sleep apnoea. Eur Respir J 25(5):820–828. doi:10.1183/09031936.05.00103204
Dyugovskaya L, Lavie P, Lavie L (2005) Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann N Y Acad Sci 1051:340–350. doi:10.1196/annals.1361.076
van Buul JD, Hordijk PL (2004) Signaling in leukocyte transendothelial migration. Arterioscler Thromb Vasc Biol 24(5):824–833. doi:10.1161/01.ATV.0000122854.76267.5c
Tzima E et al (2005) A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 437(7057):426–431. doi:10.1038/nature03952
Greenberg H et al (2006) Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. Biochem Biophys Res Commun 343(2):591–596. doi:10.1016/j.bbrc.2006.03.015
Minoguchi K et al (2004) Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 126(5):1473–1479. doi:10.1378/chest.126.5.1473
Paigen B et al (1985) Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 57(1):65–73. doi:10.1016/0021-9150(85)90138-8
Stewart-Phillips JL, Lough J (1991) Pathology of atherosclerosis in cholesterol-fed, susceptible mice. Atherosclerosis 90(2–3):211–218. doi:10.1016/0021-9150(91)90117-L
Hofker MH, van Vlijmen BJ, Havekes LM (1998) Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis. Atherosclerosis 137(1):1–11. doi:10.1016/S0021-9150(97)00266-9
Jun JC et al. (2008) Intermittent hypoxia accelerates aortic atherosclerosis in ApoE deficient mice. In: American Thoracic Society 2008 International Conference. Am J Resp Crit Care Med 177, Meeting abstract, 2008, Toronto, Canada
Arnaud C et al. (2008) Chronic intermittent hypoxia accelerates atherosclerotic plaque formation in ApoE knockout mice independently of cholesterol levels. In: European Respiratory Society 2008 International Conference. Eur Resp J 32(suppl 52), Meeting abstract, 2008, Berlin, Germany.
Acknowledgments
This work was supported by a grant from AGIR@dom to CA and MD. CA is recipient of fellowship from the Fondation pour la Recherche Médicale (France).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arnaud, C., Dematteis, M., Pepin, JL. et al. Obstructive sleep apnea, immuno-inflammation, and atherosclerosis. Semin Immunopathol 31, 113–125 (2009). https://doi.org/10.1007/s00281-009-0148-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00281-009-0148-5